Keyphrases
Synaptic Dysfunction
100%
MAPK Inhibitors
97%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
85%
Alzheimer's Disease
75%
Cognitive Dysfunction
66%
Brain Penetrant
64%
Drug Candidates
62%
Inflammatory Cytokines
58%
Behavioral Deficits
53%
Alzheimer's Disease Model
50%
Mouse Model
50%
Small Molecules
47%
Neuroinflammation
44%
Neuropsychiatric Disorders
40%
Protein Kinase
38%
Isoform Selectivity
38%
Neurologic Disorders
35%
Alzheimer's Disease Patient
35%
Amyloid Pathology
35%
Vascular Pathology
35%
Attenuation
35%
Inhibitor Drug
35%
Protein Kinase Inhibitors
35%
Kinase Inhibitor
33%
Highly Selective
31%
Comorbid
29%
Hyperhomocysteinemia
29%
Glia
29%
Disease Progression
27%
Central Nervous System
26%
Cytokine Production
23%
Anti-neuroinflammation
23%
Behavioral Dysfunction
22%
Neurodegenerative Diseases
22%
Small Molecule Drugs
20%
Microglia
20%
Disease-modifying Therapy
18%
Dementia
18%
Secondary Pharmacology
17%
Synaptic Plasticity
17%
Memory Impairment
17%
Anti-inflammatory Drugs
17%
Nucleic Acid Bases
17%
Therapeutic Treatment
17%
Chemical Probes
17%
Lactone Derivatives
17%
Comorbidity
17%
Metabolic Markers
17%
Ï„-induced
17%
Polyalthia Longifolia
17%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
94%
Cognitive Defect
77%
Cytokine
71%
Mouse Model
65%
Nervous System Inflammation
53%
Protein Kinase Inhibitor
41%
Amyloid Protein
40%
Pharmacodynamics
37%
Neurologic Disease
35%
Phosphotransferase Inhibitor
35%
Diseases
32%
Mitogen Activated Protein Kinase P38
26%
Serotonin 2B Receptor
25%
Disease Exacerbation
23%
Protein Kinases
23%
Tumor Necrosis Factor
22%
Receptor
19%
2,5-Dimethoxy-4-iodoamphetamine
17%
Normal Human
17%
Antiinflammatory Agent
17%
Lactone Derivative
17%
Tolerability
17%
Human Study
17%
Malignant Neoplasm
17%
Polo Like Kinase 4
17%
Vascular Disease
17%
Memory Disorder
17%
Nucleic Acid Base
17%
Chlordane
17%
Amyloid Plaque
17%
Enzyme-Linked Immunosorbent Assay
17%
Interleukin 6
17%
Pharmacokinetics
17%
Syndrome
17%
Casein Kinase
14%
Cyclic AMP Dependent Protein Kinase
14%
Anti-Inflammatory Drug
13%
Phosphotransferase
11%
Drug Discovery
11%
Pathophysiology
11%
Brain Disease
8%
Guanosine Phosphate
8%
Lead Compound
8%
Placebo
8%
Experimental Therapeutic
8%
Clinical Trial
8%
Biological Marker
8%
Cellular Imaging
8%
Intracranial Tumor
8%
Confocal Microscopy
8%
Neuroscience
Alzheimer's Disease
94%
Cognitive Disorders
65%
Amyloid Protein
55%
P38 Mitogen-Activated Protein Kinases
53%
Protein Kinases
38%
Proinflammatory Cytokine
35%
Vascular Disease
35%
In Vivo
35%
Kinase
29%
5-HT2B Receptor
25%
Casein Kinase
24%
Central Nervous System
17%
Memory Disorder
17%
Intracellular Signaling
17%
2,5-Dimethoxy-4-iodoamphetamine
17%
Receptor
17%
Brain Disease
17%
Hippocampus
15%
Neurodegenerative Disorder
14%
Glia
13%
Spatial Memory
11%
Synaptic Plasticity
10%
Cytokine Production
8%
Guanosine Monophosphate
8%
Anti-Inflammatory
8%
Tauopathy
7%
Behavior (Neuroscience)
6%
Tau Protein
6%
Retina S Antigen
5%
Serotonin
5%
Receptor Antagonist
5%
Hyperphosphorylation
5%
